Results 1 to 10 of about 42,112 (176)

Treatment of hypertrophic scars with ablative fractional carbon dioxide laser assisted with different topical triamcinolone delivery ways

open access: yesHeliyon, 2023
Objectives: Ablative fractional carbon dioxide laser has been used with triamcinolone to treat hypertrophic scars, resulting in promising success rates. However, there are different topical triamcinolone delivery methods used in scar treatment. To assess
Junyi Zhou   +6 more
doaj   +1 more source

“Dye another day!” – dyes in ophthalmology

open access: yesIndian Journal of Ophthalmology, 2023
Background: Dyes are substances that are an integral part of ocular procedures and surgeries. In Clinical practice, dyes help in better visualization and aid in diagnoses of ocular surface disorders.
John S Vinitha   +3 more
doaj   +1 more source

Resistance band training after triamcinolone acetonide injection for subacromial bursitis: A randomized clinical trial

open access: yesJournal of Rehabilitation Medicine, 2021
Objective: To investigate the effect of progressive resistance training using resistance (elastic) bands on subacromial bursitis following triamcinolone acetonide injection. Design: Randomized clinical trial.
Pengfei Zhu   +5 more
doaj   +1 more source

Intravitreal Triamcinolone [PDF]

open access: yesOphthalmologica, 2010
<i>Background:</i> To provide an update on the intravitreal use of triamcinolone acetonide. <i>Methods:</i> Review of literature regarding triamcinolone-related research. <i>Results:</i> After the introduction of bevacizumab and ranibizumab into clinical practice, intravitreal triamcinolone has lost its leading ...
Yong, Tao, Jost B, Jonas
openaire   +2 more sources

Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema:a meta-analysis [PDF]

open access: yesInternational Journal of Ophthalmology, 2013
AIM: To compare the efficacy of the sole intravitreal triamcinolone (IVT) versus intravitreal bevacizumab (IVB) alone or IVB combined with IVT in the treatment of diabetic macular edema (DME).METHODS: Pertinent publications were identified through ...
Xiao-Ling Zhang   +5 more
doaj   +1 more source

Comparison of the efficacy of intra-articular platelet-rich plasma with intra-articular steroid in the management of pain due to sacroiliac joint dysfunction

open access: yesIndian Journal of Pain, 2023
Background: Platelet-rich plasma (PRP) has proved to be beneficial due to its remodeling property in various conditions in the past. When given intra-articularly, it may also provide adequate analgesia in low back pain.
Priyanka Dev   +5 more
doaj   +1 more source

Comparison of the Pharmacokinetic Properties of Triamcinolone and Dexamethasone for Local Therapy of the Inner Ear

open access: yesFrontiers in Cellular Neuroscience, 2019
Some forms of triamcinolone may provide alternate options for local therapy of the inner ear in addition to the steroids currently in use. We compared the perilymph pharmacokinetics of triamcinolone-acetonide, triamcinolone, and dexamethasone, each ...
Alec Nicholas Salt   +3 more
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

Treatment of oral submucous fibrosis with local injection of salvia miltiorrhiza combined with triamcinolone ace⁃ tonide: a meta⁃analysis

open access: yes口腔疾病防治, 2018
Objective To evaluate the efficacy of the local injection of Salvia miltiorrhiza combined with triamcino⁃ lone acetonide and triamcinolone acetonide alone in the treatment of oral submucous fibrosis (OSF).
LIU Gui   +3 more
doaj   +1 more source

Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% [PDF]

open access: yes, 2012
Mometasone furoate, a potent glucocorticoid (class III) with a favorable benefit/risk ratio, has emerged as a standard medication for the treatment of inflammatory skin disorders.
Ayres JW   +30 more
core   +1 more source

Home - About - Disclaimer - Privacy